Get the Stockscreener App
3.08
2.84%
-0.09
Calcimedica Inc stock is traded at $3.08, with a volume of 33,051.
It is down -2.84% in the last 24 hours and up +2.67% over the past month.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
See More
Previous Close:
$3.17
Open:
$3.17
24h Volume:
33,051
Relative Volume:
0.48
Market Cap:
$43.03M
Revenue:
-
Net Income/Loss:
$-20.87M
P/E Ratio:
-1.925
EPS:
-1.6
Net Cash Flow:
$-21.21M
1W Performance:
+14.07%
1M Performance:
+2.67%
6M Performance:
+44.60%
1Y Performance:
-40.19%
1-Day Range:
$3.07
$3.2599
1-Week Range:
$2.72
$3.38
52-Week Range:
$1.42
$5.97
Calcimedica Inc Stock (CALC) Company Profile
Name
Calcimedica Inc
Sector
Industry
Phone
858-952-5500
Address
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
3.08 | 44.29M | 0 | -20.87M | -21.21M | -1.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Calcimedica Inc Stock (CALC) Latest News
Understanding CalciMedica Inc.’s price movementLong Setup & Advanced Technical Analysis Signals - Newser
Will CalciMedica Inc. see short term momentumNew Guidance & Free Technical Pattern Based Buy Signals - Newser
Strategies to average down on CalciMedica Inc.Quarterly Portfolio Summary & Weekly High Potential Alerts - Newser
CalciMedica Inc. stock trendline breakdown2025 Fundamental Recap & Weekly High Return Forecasts - Newser
How to monitor CalciMedica Inc. with trend dashboards2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - Newser
Will CalciMedica Inc. benefit from macro trendsTrade Risk Summary & Real-Time Chart Pattern Alerts - Newser
What is CalciMedica Inc.’s valuation compared to sector2025 Big Picture & Low Risk High Win Rate Stock Picks - خودرو بانک
Does CalciMedica Inc. stock benefit from AI growthQuarterly Portfolio Summary & Safe Entry Trade Reports - خودرو بانک
Is CalciMedica Inc. stock a value trapPortfolio Profit Report & Daily Stock Momentum Reports - خودرو بانک
Will CalciMedica Inc. benefit from AI trends2025 Technical Patterns & Daily Growth Stock Investment Tips - خودرو بانک
Intraday pattern recognizer results for CalciMedica Inc.July 2025 Catalysts & Smart Investment Allocation Insights - Newser
Is CalciMedica Inc. stock ready for a breakoutJuly 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Tools to assess CalciMedica Inc.’s risk profileJuly 2025 Big Picture & Risk Controlled Daily Plans - Newser
Can CalciMedica Inc. scale operations efficiently2025 Major Catalysts & Weekly High Return Stock Opportunities - خودرو بانک
What data driven models say about CalciMedica Inc.’s futureTrade Signal Summary & Safe Entry Zone Identification - Newser
Does CalciMedica Inc. show high probability of reboundEarnings Risk Report & Long-Term Investment Growth Plans - Newser
How moving averages guide CalciMedica Inc. tradingWatch List & Verified Short-Term Plans - Newser
Will CalciMedica Inc. stock recover after earningsMarket Sentiment Summary & Expert Verified Stock Movement Alerts - خودرو بانک
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Eastern Progress
Should you hold or exit CalciMedica Inc. now2025 Trading Recap & Precise Trade Entry Recommendations - Newser
Should I hold or sell CalciMedica Inc. now2025 Geopolitical Influence & Safe Entry Zone Identification - خودرو بانک
Combining machine learning predictions for CalciMedica Inc.Jobs Report & AI Driven Stock Reports - Newser
Real time alert setup for CalciMedica Inc. performanceQuarterly Trade Review & Long-Term Safe Investment Ideas - Newser
Developing predictive dashboards with CalciMedica Inc. dataJuly 2025 Momentum & Entry and Exit Point Strategies - Newser
Published on: 2025-09-03 05:26:55 - خودرو بانک
What indicators show strength in CalciMedica Inc.Trade Signal Summary & Weekly High Conviction Trade Ideas - Newser
Risk vs reward if holding onto CalciMedica Inc.July 2025 Summary & Real-Time Stock Price Movement Reports - Newser
CalciMedica’s CBO Makes a Bold Stock Purchase! - TipRanks
CalciMedica shares rise 3.23% after-hours as CEO to present at H.C. Wainwright conference. - AInvest
CalciMedica director Roberts buys shares worth $28,531 By Investing.com - Investing.com Australia
Analyst Upgrade: Is CalciMedica Inc. stock a value trapPortfolio Update Summary & High Conviction Trade Alerts - خودرو بانک
Is CalciMedica Inc. building a consolidation base2025 Price Targets & Entry Point Confirmation Alerts - Newser
CalciMedica director Roberts buys shares worth $28,531 - Investing.com
CalciMedica Inc. stock chart pattern explainedJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Is CalciMedica Inc. showing signs of accumulation2025 Year in Review & Verified Chart Pattern Signals - Newser
Can CalciMedica Inc. stock double in the next yearMarket Risk Analysis & Safe Investment Capital Preservation Plans - خودرو بانک
Does CalciMedica Inc. have pricing powerIPO Watch & Verified Technical Signals - خودرو بانک
How much upside does CalciMedica Inc. haveJuly 2025 Action & Long-Term Investment Growth Plans - خودرو بانک
Fibonacci Support Holding Strong in CalciMedica Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Calcimedica Inc Stock (CALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):